Kandemir, E. Et Al. 2005. Pre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , vol.33, no.3 , 319-328.

Kandemir, E., Mayadagli, A., Turken, O., Yaylaci, M., & Ozturk, A., (2005). Pre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , vol.33, no.3, 319-328.

Kandemir, EG Et Al. "Pre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer," JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , vol.33, no.3, 319-328, 2005

Kandemir, EG Et Al. "Pre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer." JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , vol.33, no.3, pp.319-328, 2005

Kandemir, E. Et Al. (2005) . "Pre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer." JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , vol.33, no.3, pp.319-328.

@article{article, author={EG Kandemir Et Al. }, title={Pre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer}, journal={JOURNAL OF INTERNATIONAL MEDICAL RESEARCH}, year=2005, pages={319-328} }